Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00391807).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932321).
- Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Study of Safety and Immunogenicity of Fluzone® in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Immunogenicity of Fluzone® in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831675).
- Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: Complete Statistical AnalysisIndependent statistical analysis of Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF…
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): Complete Statistical AnalysisIndependent statistical analysis of Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257462).
- Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are…
- Study Of Sunitinib With Capecitabine In Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With Capecitabine In Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00662025).
- Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553696).
- Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: primary endpoint results, effect estimate with confidence interval,…
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Aliviado DSD Caregiving Mastery Program: Complete Statistical AnalysisIndependent statistical analysis of Study of the Aliviado DSD Caregiving Mastery Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05630014).
- Study of the Bruton’s Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty: Complete Statistical AnalysisIndependent statistical analysis of Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy: primary endpoint results, effect estimate with confidence interval,…
- Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma: Complete Statistical AnalysisIndependent statistical analysis of Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses: Complete Statistical AnalysisIndependent statistical analysis of Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD): Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy: Complete Statistical AnalysisIndependent statistical analysis of Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture: Complete Statistical AnalysisIndependent statistical analysis of Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Tremelimumab in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Tremelimumab in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02527434).
- Study of Trilipix Effects on Lipids and Arteries: Complete Statistical AnalysisIndependent statistical analysis of Study of Trilipix Effects on Lipids and Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01025492).
- Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet: Complete Statistical AnalysisIndependent statistical analysis of Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…